Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Br J Haematol. 2013 Nov 26;164(5):653–658. doi: 10.1111/bjh.12671

Table I.

Characteristics of LPL/WM cases and controls

LPL/WM cases (n=693) Controls (n=200,000)
Gender
Male 328 (47.3%) 106172 (53.1%)
Female 365 (52.3%) 93828 (46.9%)
Age, years
66-69 99 (14.3%) 33780 (16.9%)
70-74 149 (21.5%) 52008 (26%)
75-79 200 (28.9%) 50440 (25.2%)
80-84 140 (20.2%) 36097 (18%)
85+ 105 (15.2%) 27675 (13.8%)
Selection year
1992-1994 91 (13.1%) 31364 (15.7%)
1995-1998 127 (18.3%) 39843 (19.9%)
1999-2005 475 (68.5%) 128793 (64.4%)
Race/ethnicity
Non-Hispanic White 625 (90.2%) 166827 (83.4%)
Non-Hispanic Black 30 (4.3%) 13949 (7%)
Other 38 (5.5%) 19223 (9.6%)
Duration of Medicare coverage, months
13-60 183 (26.4%) 57440 (28.7%)
61-120 306 (44.2%) 97485 (48.7%)
121-180 158 (22.8%) 35805 (17.9%)
181-240 46 (6.6%) 9270 (4.6%)

Abbreviations: LPL/WM: Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinaemia